Stphane Milot - Boralex Director Relations
| BRLXF Stock | USD 21.40 0.33 1.52% |
Insider
Stphane Milot is Director Relations of Boralex
| Phone | 819 363 6363 |
| Web | https://www.boralex.com |
Boralex Management Efficiency
The company has return on total asset (ROA) of 0.0189 % which means that it generated a profit of $0.0189 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0216 %, meaning that it generated $0.0216 on every $100 dollars invested by stockholders. Boralex's management efficiency ratios could be used to measure how well Boralex manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jessica Woelfel | Ormat Technologies | 47 | |
| Douglas Christie | Brookfield Renewable Corp | N/A | |
| Assaf Ginzburg | Ormat Technologies | 49 | |
| Jan Gaalen | Energy Vault Holdings | 67 | |
| Mark Carney | Brookfield Renewable Corp | N/A | |
| Jennifer Mazin | Brookfield Renewable Corp | 50 | |
| Andre Flores | Brookfield Renewable Corp | N/A | |
| Marta Jorge | Atlantica Sustainable Infrastru | N/A | |
| Samuel Chong | Fluence Energy | 50 | |
| Dustin Weber | Altus Power | 43 | |
| E ONeal | Clearway Energy Class | 69 | |
| Jeffrey Blidner | Brookfield Renewable Corp | 72 | |
| Manavendra Sial | Fluence Energy | ||
| Julie Babcock | Clearway Energy Class | N/A | |
| Calvin Bancroft | Excelerate Energy | 72 | |
| Anthony Savino | Altus Power | 66 | |
| Marek Wolek | Fluence Energy | N/A | |
| Ajay Tripathi | Renew Energy Global | N/A | |
| Ori Rosenzweig | Ellomay Capital | 47 | |
| Eleazar Filho | Brookfield Renewable Corp | 63 | |
| Lars Norell | Altus Power | 52 | |
Management Performance
| Return On Equity | 0.0216 | |||
| Return On Asset | 0.0189 |
Boralex Leadership Team
Elected by the shareholders, the Boralex's board of directors comprises two types of representatives: Boralex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boralex. The board's role is to monitor Boralex's management team and ensure that shareholders' interests are well served. Boralex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boralex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Isabelle Fontaine, Sr Communications | ||
| MarieJose Arsenault, Ex Officer | ||
| Julie Cusson, VP CSR | ||
| Bruno Guilmette, CFO, Vice President | ||
| Nicolas Wolff, COO, Vice President | ||
| Pascal Hurtubise, Vice President Corporate Secretary, Chief Legal Officer | ||
| Rabindra Mishra, Deputy Europe | ||
| Hugues Girardin, VP of Devel. | ||
| Stphane Milot, Director Relations | ||
| Patrick Decostre, General Manager of Europe |
Boralex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Boralex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0216 | |||
| Return On Asset | 0.0189 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 4.95 B | |||
| Shares Outstanding | 102.76 M | |||
| Shares Owned By Insiders | 0.66 % | |||
| Shares Owned By Institutions | 55.76 % | |||
| Price To Earning | 60.93 X | |||
| Price To Book | 2.33 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Boralex Pink Sheet
Boralex financial ratios help investors to determine whether Boralex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boralex with respect to the benefits of owning Boralex security.